NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/19/2024
Back to search
Official data from USPTO
BLEPHADERM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BLEPHADERM
ST13
US500000079033964Class
3, 5
Filing
79033964
Registration
3651209
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
03/19/2024
Classification
Registered
Trademark type
Word
Nice classes
3, 5
Filing date
12/08/2006
Registration date
07/07/2009
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/12/2016
Last transaction
03/16/2016
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
FR
Examiner
MAKHDOOM,SAIMA
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
L. T. (pessoa física)
P. D. (pessoa física)
Representatives
G PATRICK SAGE HUESCHEN & SAGE PLLC
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Transdermal device for cosmetic use for soothing and decongesting irritated eyespatch
Class 5
Transdermal patch for medical use in the treatment of soothing and decongesting irritated eyes
Publications
History of USPTO decisions and trademark events.
43 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/05/2018
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
05/19/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/01/2017
XXCR
GENERIC MADRID TRANSACTION CREATED
03/01/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/22/2016
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/27/2016
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/12/2016
C71T
CANCELLED SECTION 71
02/12/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/06/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/14/2009
FIMP
FINAL DISPOSITION PROCESSED
10/14/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/07/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2009
PUBO
PUBLISHED FOR OPPOSITION
04/21/2009
NPUB
NOTICE OF PUBLICATION
04/01/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/16/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/17/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/16/2009
CNRT
NON-FINAL ACTION MAILED
08/11/2008
CNRT
NON-FINAL ACTION WRITTEN
08/08/2008
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/01/2008
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/17/2008
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/17/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/17/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/17/2008
CNRT
NON-FINAL ACTION MAILED
12/17/2007
CNRT
NON-FINAL ACTION WRITTEN
12/14/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/25/2007
ALIE
ASSIGNED TO LIE
10/25/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/17/2007
PAPER RECEIVED
09/17/2007
RFNT
REFUSAL PROCESSED BY IB
04/05/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/21/2007
RFRR
REFUSAL PROCESSED BY MPU
03/21/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/19/2007
CNRT
NON-FINAL ACTION WRITTEN
03/18/2007
DOCK
ASSIGNED TO EXAMINER
03/16/2007
NWAP
NEW APPLICATION ENTERED
02/17/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/15/2007
Continuous trademark protection
Get notified about every new filing that threatens BLEPHADERM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.